Dougherty Wealth Advisers’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,230
Closed -$45K 141
2020
Q4
$45K Sell
1,230
-66
-5% -$2.42K 0.07% 107
2020
Q3
$45K Hold
1,296
0.16% 105
2020
Q2
$40K Hold
1,296
0.15% 108
2020
Q1
$40K Hold
1,296
0.16% 102
2019
Q4
$48K Hold
1,296
0.15% 111
2019
Q3
$44K Sell
1,296
-1,371
-51% -$49.9K 0.14% 113
2019
Q2
$110K Buy
2,667
+1,371
+106% +$54.4K 0.31% 64
2019
Q1
$52K Sell
1,296
-527
-29% -$21.1K 0.18% 101
2018
Q4
$72K Buy
+1,823
New +$75.7K 0.24% 78

Other funds holding PFE

Dougherty Wealth Advisers's PFE Position: Q1 2021 in Review

Dougherty Wealth Advisers sold out of Pfizer (PFE) in Q1 2021, closing a stake of 1,230 shares — an estimated $45K sold.

Dougherty Wealth Advisers first reported a position in PFE in Q4 2018 and held it in 9 quarters. The position peaked at $110K in Q2 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Dougherty Wealth Advisers reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Dougherty Wealth Advisers sold 1,230 Pfizer shares in Q1 2021, an estimated $45K.
  • Dougherty Wealth Advisers first reported a position in Pfizer in Q4 2018 and held it in 9 quarters.
  • Dougherty Wealth Advisers's Pfizer position peaked at $110K in Q2 2019.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Dougherty Wealth Advisers's 13F filing for Q1 2021, filed 6 May 2021.